SAN DIEGO, April 15, 2019 /PRNewswire-PRWeb/ -- Calidi Biotherapeutics, Inc., a clinical?stage biotherapeutics company
Mr. Camaisa shared the progress that Calidi Biotherapeutics has made, and what the future holds for the San Diego-based biotech. Mr. Camaisa also shared that his passion for finding a cure for cancer is due to the loss of his father to the disease.
"During my Father's illness, I searched for a solution, a clinical trial, anything. Unfortunately, there was nothing at the time that could help my father," said Allan J. Camaisa, CEO and Chairman of Calidi Biotherapeutics. "Fast forward to Calidi, and our patented technology: it teaches a patient's immune system to recognize, fight and kill cancer cells. In our 26 patient safety study, no one experienced any significant side effects."
To learn more about Calidi Biotherapeutics and to view the interviews, please visit Calidi Biotherapeutics website: https://calidibio.com/2019/04/12/good-morning-san-diego-calidi-bio-treatments-discussed/
SOURCE Calidi Biotherapeutics
Subscribe to our Free Newsletters!